Lentiviral Gene Transfer of the Chemokine Antagonist RANTES 9-68 Prolongs Heart Graft Survival

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Transplantation

• Publication date

  2006-01-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.tp.0000194859.98504.9ePMID 16436968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lentivirus-mediated gene transfer of viral interleukin-10 delays but does not prevent cardiac allograft rejection

  2005cited by this paper
• Helper-dependent adenovirus vectors devoid of all viral genes cause less myocardial inflammation compared with first-generation adenovirus vectors

  2004cited by this paper
• Chemokine receptor‐dependent alloresponses

  2003cited by this paper
• Feline Immunodeficiency Virus‐Mediated Viral Interleukin‐10 Gene Transfer Prolongs Non‐Vascularized Cardiac Allograft Survival

  2003cited by this paper
• Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction as a Method for Determining Lentiviral Vector Titers and Measuring Transgene Expression

  2003cited by this paper
• Multiply Attenuated, Self-Inactivating Lentiviral Vectors Efficiently Deliver and Express Genes for Extended Periods of Time in Adult Rat Cardiomyocytes In Vivo

  2003cited by this paper
• Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants1

  2003cited by this paper
• Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes.

  2003cited by this paper
• Met-RANTES improves acute-rejection-induced microvascular injury in rat small bowel transplantation.

  2002cited by this paper
• Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo

  2002cited by this paper
• CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model.

  2001cited by this paper
• Expression of chemokines and chemokine receptors during human renal transplant rejection.

  2001cited by this paper
• A Non-peptide Functional Antagonist of the CCR1 Chemokine Receptor Is Effective in Rat Heart Transplant Rejection*

  2001cited by this paper
• Beneficial effects of targeting CCR5 in allograft recipients.

  2001cited by this paper
• Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.

  2000cited by this paper
• The Role of the CC Chemokine, RANTES, in Acute Lung Allograft Rejection1

  2000cited by this paper
• Tolerance to Cardiac Allografts Via Local and Systemic Mechanisms After Adenovirus-Mediated CTLA4Ig Expression1

  2000cited by this paper
• Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

  2000cited by this paper
• Endocytosis and Recycling of the HIV Coreceptor Ccr5

  2000cited by this paper
• Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors

  1999influential reference
• Species-Specific, Postentry Barriers to Primate Immunodeficiency Virus Infection

  1999cited by this paper
• Met‐RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment

  1999cited by this paper
• A Third-Generation Lentivirus Vector with a Conditional Packaging System

  1998cited by this paper
• Synthetic full-length and truncated RANTES inhibit HIV-1 infection of primary macrophages.

  1998cited by this paper
• RANTES chemokine expression is related to acute cardiac cellular rejection and infiltration by CD45RO T-lymphocytes and macrophages.

  1998cited by this paper
• HIV-specific T Cell Cytotoxicity Mediated by RANTES Via the Chemokine Receptor CCR3

  1998cited by this paper
• Synthetic full‐length and truncated RANTES inhibit HIV‐1 infection of primary macrophages

  1998cited by this paper
• RANTES and MCP-3 Antagonists Bind Multiple Chemokine Receptors (*)

  1996cited by this paper
• Modulation of Human Muscle Sodium Channels by Intracellular Fatty Acids Is Dependent on the Channel Isoform*

  1996cited by this paper

• Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine.

  2023cites this paper
• Myocardial Gene Expression Profiling to Predict and Identify Cardiac Allograft Acute Cellular Rejection: The GET-Study

  2016cites this paper
• Gene Transfer of the S24F Regulated on Activation Normal T-Cell Expressed and Secreted–Chemokine Ligand 5 Variant Attenuates Cardiac Allograft Rejection

  2014cites this paper
• A Combination of Local Inflammation and Central Memory T Cells Potentiates Immunotherapy in the Skin

  2012cites this paper
• Myeloid-Derived Suppressor Cells and CCL5 Intragraft Regulatory T Cell Localization by Control of Transplant Tolerance and

  2012cites this paper
• Control of Transplant Tolerance and Intragraft Regulatory T Cell Localization by Myeloid-Derived Suppressor Cells and CCL5

  2012cites this paper
• Gene Therapy in Organ Transplantation

  2012cites this paper
• Engineering and screening the N-terminus of chemokines for drug discovery.

  2011cites this paper
• Targeted gene therapy for the treatment of heart failure.

  2011cites this paper
• Canadian Journal of Cardiology Symposium Review Targeted Gene Therapy for the Treatment of Heart Failure

  2011cites this paper
• Inhibition sélective de la costimulation CD28-CD80/86 en transplantation : mécanismes d'action des cellules régulatrices

  2011cites this paper
• Chemokines and Cytotoxic Effector Molecules in Rejection

  2011cites this paper
• Genetically modified cells in regenerative medicine and tissue engineering.

  2010cites this paper
• Modalities and future prospects of gene therapy in heart transplantation.

  2009cites this paper
• Gene therapy in transplantation.

  2009cites this paper
• Intragraft gene expression profile associated with the induction of tolerance

  2008cites this paper
• Donor-Specific Tolerance

  2008cites this paper
• Targeting of interleukin‐10 is superior to cytotoxic T‐lymphocyte associated antigen 4 with human immunoglobulin G1 for the prevention of chronic allograft deterioration in organ transplantation

  2008cites this paper
• Engineering physiologically controlled pacemaker cells with lentiviral HCN4 gene transfer

  2008cites this paper
• Chemokines in Transplantation Biology

  2007cites this paper
• Chemokines in vascular remodeling

  2007cites this paper
• An anti-major histocompatibility complex class I intrabody protects endothelial cells from an attack by immune mediators.

  2006cites this paper